Recombinant
-
Master file for recombinant albumin
Novozymes Biopharma announces that the US FDA Center for Biologics Evaluation and Research (FDA / CBER) has accepted a Type IV Master File for its recombinant albumin, albucult. The dossier which contains proprietary information on the manufacture a…
Recombinant | 30 September 2010
-
Rice-derived Recombinant Human Transferrin
A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates the uptake, transport and utilisation of iron fo…
Recombinant | 21 June 2010
-
Amsbio Introduces Non-Animal Recombinant Proteins for Cell Culture
Amsbio has announced a range of recombinant proteins that can substitute extracellular matrix proteins that are currently extracted from mouse sarcoma. The Mussel Adhesive Protein based matrix (MAPTrix) ECM line of products are coating reagents wi…
Recombinant | 07 May 2010
-
Siemens Supplies Automation Solution to Baxter in Singapore
Siemens has been awarded a lump-sum multi-million dollar contract to supply the automation for the Singapore Recombinant plant of Baxter Bioscience Manufacturing. The former will provide basic and detail engineering services and will deliver, ins…
Recombinant | 23 November 2009
-
InVivo and Cevec Sign Agreement for Production of Recombinant Proteins
Cevec Pharmaceuticals and the contract manufacturer InVivo BioTech Services have announced the signing of a strategic license agreement. This license enables the latter to offer its customers the production of their diagnostic ad preclinical grad…
Recombinant | 11 November 2009
-
InVitria Launches Cell Culture Supplements
InVitria has announced the launch of Optiferrin, an animal-free recombinant transferrin for use in mammalian cell culture. It is a cell culture supplement which supports cell growth by regulating the amount of iron that is transported to the cell…
Recombinant | 13 October 2009
-
First Industrial Production Of Recombinant Pig Liver Esterase
DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has successfully launched PharmaPLE during the Informex tradeshow in New Orleans. PharmaPLE is a recombinant pig liver esterase, which has been scaled and applied successfully …
Recombinant | 07 March 2008
